Pharma major Novartis falls 10% after three drug trial setbacks
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors
Originally published by CNBC. Summary and curation by DutyStation News.
📰 Related Stories
📰 General
Friday’s Android app deals and freebies: Greak Memories of Azur, Fernz Gate, Legna Tactica, more
9to5Google44m ago
📰 General
FAA tees up $875M AI tool to help manage air traffic congestion
Ars Technica45m ago
📰 General
Uber to Pay $40 Million to Parents of Woman Fatally Hit by Car
NYT Tech1h ago
📰 General
Disney’s first CTO is Character.AI’s former CEO
The Verge1h ago
📰 General
McDonald's is the new 'Value Meal,' says trader Mike Khouw
CNBC1h ago
📰 General
Disney’s first CTO led an AI startup it once accused of copying its characters
TechCrunch2h ago